As a further verification, we performed an invasion assay with Matrigel and observed that circ-EGFR knockdown significantly increased the invasive abilities in CRC cells under cetuximab treatment (Fig. EV3D). The gene discussed is EGFR; the disease is colorectal carcinoma.